Trials / Unknown
UnknownNCT05579301
Study of Comprehensive ANd Multimodal Marker-based Cohort of Progressive Supranuclear Palsy(PSP)
Biomarker Development for Progressive Supranuclear Palsy Through Multi-dimensional SNU-PSP Cohort Database
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this cohort study is to develop a reliable biomarker in progressive nuclear palsy (PSP).
Detailed description
Progressive supranuclear palsy is a rapidly progressive neurodegenerative disease without a cure. Thus, the development of a biomarker that reflects and monitors disease severity in PSP is critical for early diagnosis and performing a successful clinical trial. Thus, we will prospectively recruit patients with PSP and collect comprehensive clinical, imaging and blood biomarkers at baseline with longitudinal follow-up for 1 year.
Conditions
Timeline
- Start date
- 2021-12-19
- Primary completion
- 2024-12-19
- Completion
- 2025-02-28
- First posted
- 2022-10-13
- Last updated
- 2022-10-13
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05579301. Inclusion in this directory is not an endorsement.